Serum carcinoembryonic antigen (CEA) is the most widely used tumor marker for colorectal malignancies but few studies have examined the clinical utility of CEA in patients with rectal cancer.
A new research paper was published in Oncotarget’s Volume 16 on January 21, 2025, titled “Assessment of cfDNA release dynamics during colorectal cancer surgery.” ...
Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...
Tumor M2 Pyruvate Kinase: A Tumor Marker and its Clinical Application in Gastrointestinal Malignancy
In combination with established tumor markers, EDTA-plasma M2-PK is a useful ... M2-PK in EDTA-plasma even proves superiority as compared with CEA. Fecal Tumor M2-PK testing resembles a good ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback